NASDAQ:ISTA - Ista Pharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ISTA Pharmaceuticals, Inc. (ISTA) is a commercial-stage, multi-specialty pharmaceutical company. The Company is engaged in developing, marketing and selling its own products in the United States and Puerto Rico. ISTA is a prescription eye care business in the United States and has an allergy drug franchise. ISTA manufactures its finished good products through third-party contracts. ISTA in-licenses or acquires new products and technologies to add to its internal development. Its products and product candidates seek to treat allergy and diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye and ocular and nasal allergies. It has four products available for sale in the United States and Puerto Rico: BROMDAY (bromfenac ophthalmic solution) 0.09%, BEPREVE (bepotastine besilate ophthalmic solution) 1.5%, ISTALOL (timolol maleate ophthalmic solution) 0.5% and VITRASE (hyaluronidase injection). Receive ISTA News and Ratings via Email Sign-up to receive the latest news and ratings for ISTA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:ISTA Previous Symbol CUSIPN/A Webwww.istavision.com Phone+1-949-7886000Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable Ista Pharmaceuticals (NASDAQ:ISTA) Frequently Asked Questions What is Ista Pharmaceuticals' stock symbol? Ista Pharmaceuticals trades on the NASDAQ under the ticker symbol "ISTA." Has Ista Pharmaceuticals been receiving favorable news coverage? Headlines about ISTA stock have been trending positive recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ista Pharmaceuticals earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave news articles about the specialty pharmaceutical company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the near future. How do I buy shares of Ista Pharmaceuticals? Shares of ISTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Ista Pharmaceuticals' official website? The official website for Ista Pharmaceuticals is http://www.istavision.com. How can I contact Ista Pharmaceuticals? Ista Pharmaceuticals' mailing address is #D1, 10574 Acacia Street, RANCHO CUCAMONGA, CA 91730, United States. The specialty pharmaceutical company can be reached via phone at +1-949-7886000. MarketBeat Community Rating for Ista Pharmaceuticals (NASDAQ ISTA)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 70 (Vote Outperform)Underperform Votes: 64 (Vote Underperform)Total Votes: 134MarketBeat's community ratings are surveys of what our community members think about Ista Pharmaceuticals and other stocks. Vote "Outperform" if you believe ISTA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISTA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/17/2019 by MarketBeat.com StaffFeatured Article: What is a Stop Order?